Government and policy
Pressing for Progress: Women in Dementia Research
Alzheimer’s Research UK is passionate about championing our female scientists. We spoke with some of the incredible researchers we work with about dementia research, potential barriers and how we can support women in science.
Why government must act now to make breakthroughs possible
In the three years since we launched our Manifesto 2015-2020, which outlined five areas the government could improve to support dementia research, we have seen much success and growth. Despite all this good progress, we haven’t yet reached our goal.
Dementia is conspicuously absent from new NHS priorities
In all the developments so far there has been no specific mention of dementia.
Meet Bev: the NHS as a 70-year-old woman
As the NHS celebrates its 70th birthday today, we’re reflecting on how the National Health Service has shaped and delivered medical advances and how it needs to adapt to the changing face of health today.
Prime Minister supports revolutionary early diagnosis effort
The Prime Minister announced an aim to transform the prevention, early diagnosis and treatment of a range of health conditions including dementia.
The 8 things we want the Challenge on Dementia to focus on
We’re feeding in to this review and have outlined to the government what support is needed to successfully meet the goals in the Challenge and what we hope to see beyond 2020.
Your data, your power: How you can help save lives
The potential impact of your data is what gives it so much power. Your health data, and what you decide to do with it, can help our healthcare system provide the best care possible, not just for you, but for others as well.
Why dementia doesn’t believe in gender parity
While we have known about the disproportionately high impact of dementia on women for some time, we’re not entirely clear of the reasoning behind these differences.
Behind the headlines: Pfizer scales back investment but hope remains for a dementia treatment
Recent news from the pharmaceutical industry that Pfizer is reducing its investment in dementia research has highlighted some of the barriers to research, and the increased need for shared responsibility in bringing treatments to people in need.
The top 5 issues that will impact dementia research in 2018
2018 promises to be just as busy as last year, and likely with as many changes in the political scene, some directly affecting dementia research. Amid these, Alzheimer’s Research UK will be pushing for the Government to give priority to bringing an end to the fear, harm and heartbreak of dementia.
